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Abstract
Background: Post-operative pulmonary complications add to the morbidity and mortality of surgical patients, in
particular after general anesthesia >2 hours for abdominal surgery. Whether a protective mechanical ventilation
strategy with higher levels of positive end-expiratory pressure (PEEP) and repeated recruitment maneuvers; the
“open lung strategy”, protects against post-operative pulmonary complications is uncertain. The present study aims
at comparing a protective mechanical ventilation strategy with a conventional mechanical ventilation strategy
during general anesthesia for abdominal non-laparoscopic surgery.
Methods: The PROtective Ventilation using HIgh versus LOw positive end-expiratory pressure ("PROVHILO”) trial is a
worldwide investigator-initiated multicenter randomized controlled two-arm study. Nine hundred patients scheduled
for non-laparoscopic abdominal surgery at high or intermediate risk for post-operative pulmonary complications are
randomized to mechanical ventilation with the level of PEEP at 12 cmH2O with recruitment maneuvers (the lung-
protective strategy) or mechanical ventilation with the level of PEEP at maximum 2 cmH2O without recruitment
maneuvers (the conventional strategy). The primary endpoint is any post-operative pulmonary complication.
Discussion: The PROVHILO trial is the first randomized controlled trial powered to investigate whether an open
lung mechanical ventilation strategy in short-term mechanical ventilation prevents against postoperative
pulmonary complications.
Trial registration: ISRCTN: ISRCTN70332574
Background
Mechanical ventilation is a life-saving strategy in patients
with respiratory failure. There is unequivocal evidence
that mechanical ventilation in critically ill patients has
the potential to aggravate or even initiate lung injury
[1,2]. Patients with acute lung injury (ALI) could benefit
from measures that prevent repeated collapse and re-
expansion of alveoli, including the so-called open lung
mechanical ventilation strategy with the use of higher
levels of positive end-expiratory pressure (PEEP) and
recruitment maneuvers [3]. Meta-analysis suggest this
approach can waive the need for rescue therapies due to
life-threatening hypoxemia [1], and even reduce mortality
in patients with more severe ALI [4].
Mechanical ventilation is frequently mandatory in
patients who undergo surgery. The effects of short-term
intra-operative mechanical ventilation on pulmonary
integrity are less well defined [5]. In addition, it is
uncertain whether ventilation strategies that use higher
levels of PEEP and recruitment maneuvers during the
intra-operative period are beneficial in these patients
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intra-operative atelectasis, decreasing repetitive collapse
and re-expansion of dependent lung parts, and thereby
attenuating pulmonary inflammation and coagulation
[8,9]. Use of recruitment maneuvers to open the lungs
has been found to improve the effectiveness of PEEP
with regard to gas exchange during general anesthesia
[10]. Intra-operative use of PEEP does not represent a
common practice. Indeed, an observational study con-
ducted in 28 centers in France revealed that most
patients undergoing general surgery were ventilated
without PEEP [11]. Thus, the intra-operative use of
PEEP cannot be seen as clinical standard.
Post-operative pulmonary complications, in particular
after general anesthesia >2 hours for abdominal surgery,
add to the morbidity and mortality of surgical patients
[12,13]. We hypothesize that a lung-protective mechani-
cal ventilation strategy with higher levels of PEEP and
recruitment maneuvers attenuates post-operative pul-
monary complications in patients without lung injury
(i.e., patients who do not fulfill the criteria for ALI at
the moment of surgery).
PROVHILO aims at comparing the effects of such pro-
tective strategy and conventional mechanical ventilation
in biomarkers of lung injury, post-operative pulmonary
complications, extra-pulmonary complications and
length of hospital stay in patients undergoing general
anesthesia for open abdominal surgery.
Methods
Objectives and design
The PROtective Ventilation using HIgh versus LOw
positive end-expiratory pressure ("PROVHILO”)t r i a li s
a worldwide investigator-initiated multicenter rando-
mized controlled two-arm trial.
The Institutional Review Board of the Academic Med-
ical Center - University of Amsterdam, Amsterdam, The
Netherlands, approved the trial. The PROVHILO trial is
conducted in accordance with the declaration of Hel-
sinki and was registered on October 29 2010 at http://
www.controlled-trials.com with trial identification num-
ber ISRCTN70332574.
CONSORT diagram
Figure 1 shows the CONSORT diagram of the PROV-
HILO trial.
Study population
Local investigators screen consecutive patients scheduled
for non-laparoscopic abdominal surgery in participating
centers worldwide. Demographic data on screened
patients regardless of meeting enrolment criteria are
recorded (registry: age, gender, type of surgery). A total of
900 patients are randomized to the 2 different mechanical
ventilation strategies. In the participating centers at least 2
investigators are involved with the study. One researcher
is involved with mechanical ventilation practice in the
operation room, he/she will be blinded for the randomized
intervention most closely to the time of tracheal intuba-
tion (depending on local situation) - the second investiga-
tor, blinded for randomization arm, will score the primary
and secondary post-operative endpoints.
Patients with high or intermediate risk for post-opera-
tive pulmonary complications following non-laparoscopic
abdominal surgery with general anesthesia are eligible for
participation. To identify such patients the ARISCAT
risk score (see Table 1) will be used [14]. This predictive
risk index is developed by the ARISCAT Group to assess
the individual pre-operative risk for post-operative pul-
monary complications. An ARISCAT risk score ≥ 26 is
associated with an intermediate to high risk for post-
operative pulmonary complications.
Patients planned for laparoscopic surgery are excluded
from participation, as are non-adult patients (age <18
years), patients with a body mass index >40 kg/m
2,p r e g -
nant patients (excluded by laboratory analysis), and
Patients scheduled for non–laparoscopic abdominal 
surgery at high or intermediate risk for postoperative 
pulmonary complications
Informed consent
Post-operative follow-up
Day 1,3,5 and last
day before discharge or day 90 when still admitted
Protective strategy
450 pt
Conventional strategy
450 pt
Intra-operative
PEEP 12 cm H2O
   + Recruitment maneuvers
Excluded
Randomized
900 patients
Excluded
Intra-operative
PEEP max 2 cm H2O
- Recruitment maneuvers
Drop-out Drop-out
Lost to follow-up
Figure 1 CONSORT diagram of PROVHILO. PEEP = positive end-
expiratory pressure
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Page 2 of 10patients who consented for another interventional study
or decline to participate. In addition, patients who were
on mechanical ventilation >30 minutes (e.g., because of
general anesthesia for surgery) within last 30 days, are
excluded. Other important exclusion criteria include: any
previous lung surgery, history of previous severe chronic
obstructive pulmonary disease (COPD) with (non-inva-
sive) ventilation and/or oxygen therapy at home and/or
repeated systemic corticosteroid therapy for acute
exacerbations of COPD, ALI or acute respiratory distress
syndrome expected to require prolonged post-operative
mechanical ventilation, persistent hemodynamic instabil-
ity or intractable shock (considered hemodynamic unsui-
table for the study by the patient’s managing physician),
severe cardiac disease (New York Heart Association class
III or IV, or acute coronary syndrome, or persistent ven-
tricular tachyarrhythmia’s), and recent immunosuppres-
sive medication (receiving chemotherapy or radiation
therapy within last 2 months).
All patients are asked for signed informed consent, as
required by the institutional review board in accordance
with the Declaration of Helsinki.
Randomization and intervention
Randomization is performed using a dedicated, pass-
word protected, SSL-encrypted website. Randomization
sequence is generated using random blocks and is strati-
fied per center. No blocking is applied to other trial
factors.
Patients are randomly assigned to mechanical ventila-
tion with levels of PEEP at 12 cmH2Ow i t ht h eu s eo f
recruitment maneuvers (the lung-protective strategy) or
mechanical ventilation with levels of PEEP at maximum
2c m H 2O without recruitment maneuvers (the conven-
tional strategy). The PEEP level in the protective strategy
is chosen to be 12 cmH2O, to achieve maximal interven-
tional effect without causing harm to participating
patients and to make the intervention acceptable for the
participating clinicians. The conventional strategy is cho-
sen based on a national survey in France that showed
>90% of responding anesthetists to use levels of PEEP of
0-4c m H 2O without recruitment maneuvers [11]. Since
not all available anesthesia ventilators can apply levels of
PEEP <2 cmH2O, the level of PEEP is set at a maximum
of 2 cmH2O with the conventional strategy. However the
lowest possible level of PEEP is always chosen.
Mechanical ventilation
Patients are ventilated with a volume-controlled
mechanical ventilation strategy. Although it is left to the
discretion of the attending anesthesiologist to use differ-
ent fractions of inspired oxygen, it is advised to use at
Table 1 ARISCAT risk score - Independent predictors of risk for post-operative pulmonary complications identified in
the logistic regression model
Multivariate Analysis OR (95% CI) n = 1,624 b Coefficient Risk Score†
Age (years)
≤ 50 1
51 - 80 1.4 (0.6 - 3.3) 0.331 3
>80 5.1 (1.9 - 13.3) 1.619 16
Pre-operative (SpO2,% )
≥ 96 1
91 - 95 2.2 (1.2 - 4.2) 0.802 8
≤ 90 10.7 (4.1 - 28.1) 2.375 24
Respiratory infection 5.5 (2.6 - 11.5) 1.698 17
in the last month
Pre-operative anemia (≤ 10 g/dl) 3.0 (1.4 - 6.5) 1.105 11
Surgical incision
Peripheral 1
Upper abdominal 4.4 (2.3 - 8.5) 1.480 15
Intra-thoracic 11.4 (4.9 - 26.0) 2.431 24
Duration of surgery (hours)
≤ 21
2 - 3 4.9 (2.4 - 10.1) 1.593 16
>3 9.7 (4.7 - 19.9) 2.268 23
Emergency procedure 2.2 (1.0 - 4.5) 0.768 8
High or intermediate risk for postoperative pulmonary complications following abdominal surgery: risk score ≥ 26
Abbreviations: CI, confidence interval; OR, odds ratio; SpO2, oxyhemoglobin saturation by pulse oximetry breathing air in supine position; g/dL, gram per decilitre
† The simplified risk score was the sum of each logistic regression coefficient multiplied by 10, after rounding off its value.
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oxygen saturation ≥ 92%. The inspiratory to expiratory
time ratio (I:E) is set at 1:2, and the respiratory rate is
adjusted to reach normocapnia (end-tidal carbon dioxide
partial pressure between 35 and 45 mmHg). Tidal
volumes of <8 mL/kg predicted body weight (PBW) are
advised to be used [15]. PBW is calculated according to
a predefined formula: 50 + 0.91 × (centimeters of height
- 152.4) for males and 45.5 + 0.91 × (centimeters of
height - 152.4) for females [16,17]. Tidal volumes
throughout this protocol refer to the actual inspired
tidal volume in the ventilator circuit.
Recruitment maneuver
Recruitment maneuvers, as part of the lung-protective
strategy, are performed directly after intubation, after
any disconnection from the mechanical ventilator, and
directly before tracheal extubation. Recruitment maneu-
vers should not be performed when patients are hemo-
dynamic unstable, as judged by the attending physician.
Recruitment maneuvers are not easily applied with
a v a i l a b l ea n e s t h e s i av e n t i l a t o r ss i n c en o ta l lm a c h i n e s
have an inspiratory hold function or other adequate
facilities. To obtain standardization among centers,
recruitment maneuvers are performed as follows:
1. peak inspiratory pressure limit is set at 45 cmH2O
2. tidal volume is set at 8 ml/kg PBW and respira-
tory rate at 6-8 breaths/min (or lowest respiratory
rate that anesthesia ventilator allows), while PEEP is
set at 12 cmH2O
3. inspiratory to expiratory ratio (I:E) is set at 1:2
4. tidal volumes are increased in steps of 4 ml/kg
PBW until a plateau pressure of 30-35 cmH2O
5. 3 breaths are administered with a plateau pressure
of 30-35 cmH2O
6. peak inspiratory pressure limit, respiratory rate, I:
E, and tidal volume are set back to settings preced-
ing each recruitment maneuver, while maintaining
PEEP at 12 cmH2O
Protocol drop-out
Anesthesiologists are allowed to change the ventilation
protocol at any time point upon the surgeon’s request, or
if there is any concern about patient’s safety. The level of
PEEP can be modified according to the anesthesiologist
in charge if the systolic arterial pressure drops <90
mmHg for more than 3 minutes despite intravenous fluid
infusion and/or start of vasopressors, if dosages of vaso-
pressors are at the highest level tolerated, if new arrhyth-
mias develop which are unresponsive to treatment
suggested by the Advanced Cardiac Life Support Guide-
lines [18], if there is need of massive transfusion to
maintain Ht >21% (Hb >7 mg/dl), or if there is a surgical
complication determining life-threatening situations.
Rescue therapy
In both study groups, in case of desaturation (SpO2
<90%), after excluding airway problems, severe hemody-
namic impairment and ventilator malfunction, a rescue
strategy is proposed, which improves oxygenation with
respectively a decreasing level of PEEP with increasing
FiO2 in the lung-protective strategy group, and increas-
ing levels of PEEP and FiO2 in the conventional group
(see Table 2).
Standard procedures
The study protocol stresses that routine general anesthe-
sia, post-operative pain management, physiotherapeutic
procedures and fluid management must be used in the
peri-operative as well as the post-operative period accord-
ing to each centers specific expertise and routine clinical
use, to minimize interference with the trial intervention.
However, it is suggested to perform post-operative pain
management in order to achieve a visual analogue scale
(VAS) pain score <3, to use regional or neuroaxial analge-
sia if indicated, to use physiotherapy by early mobilization,
deep breathing exercises with and without incentive spiro-
metry, and stimulation of cough in the post-operative
period, to avoid fluid overload (according to the discretion
of the responsible physicians) and to use appropriate pro-
phylactic antibiotics when indicated. Data on the applied
procedures will be collected and analysed.
Follow up
Baseline variables are collected pre-operative at the pre-
anesthetic visit or before induction of general anesthesia.
The following variables are collected; gender, age, height,
weight, functional status (independent, partially depen-
dent or totally dependent), physical status (according to
Table 2 Rescue therapies with the protective and the
conventional strategy
Protective Conventional
Step FiO2 PEEP Step FiO2 PEEP
1 0.5 12 1 0.5 2
2 0.5 10 2 0.6 2
3 0.5 8 3 0.6 3
4 0.5 6 4 0.6 4
5 0.6 6 5 0.6 5
6 0.7 6 6 0.7 5
7 0.8 6 7 0.8 5
8 0.8 4 or lower 8 0.8 6
9R M 6
See text for details.
Abbreviations: PEEP = positive end-expiratory pressure; FiO2 = fractional
inspired oxygen; RM, recruitment maneuver.
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status (heart failure, according to the New York Heart
Association (NYHA), acute coronary syndrome, or per-
sistent ventricular tachyarrhythmia’s),
COPD and use of inhalation therapy and/or steroids,
respiratory infection in the last month, smoking status,
alcohol status in the past 2 weeks, history of active can-
cer, weight loss >10% in the last 6 months, history of
diabetes mellitus, use of oral anti-diabetics, use of anti-
biotics in the last 3 months, use of statins, type of
scheduled surgery (emergency or non-emergency and
surgical procedure), transfusion of blood products in the
preceding 6 hours, vital parameters (timpanic tempera-
ture, respiratory rate, SpO2 (%), blood pressure, heart
rate), airway secretion score (the patient is required to
cough and the presence of secretion will be subjectively
evaluated; if yes: purulent or not), VAS-scores for dys-
pnea and pain, blood samples (glycemia, uremia, creati-
n i n e ,A S T ,A L T ,b i l i r u b i n ,H b ,W B Cc o u n t ,p l a t e l e t
count, PT, PTT, and biomarkers [see below]) and a
chest X-ray (assessed on mono- and bilateral infiltrate,
pleural effusion, atelectasis, pneumothorax, cardiopul-
monary edema).
During the intra-operative period variables are recorded
hourly after induction of anesthesia during the recruit-
ment maneuver. These variables include duration and type
of both anesthesia and surgical procedures, all adminis-
tered drugs during anesthesia (e.g. anesthetics, vasoactive
drugs, anti-arrhythmic medication), ventilator settings,
vital parameters, fluid- and transfusion requirements, need
of rescue therapy for hypoxemia and intra-operative com-
plications possibly related to recruitment maneuvers (e.g.
de-saturation, hypotension during recruitment maneuver,
need for vasoactive medication).
Patients are assessed at the first five post-operative days
and at the last day before discharge from the hospital. On
day 90 hospital free-days are recorded; if the patient is
still admitted to the hospital on day 90, this day will be
recorded as last day of follow-up. Clinical data and the
presence of pulmonary and extra-pulmonary postopera-
tive complications are scored; the day of development of
any complication is indicated. A chest X-ray will be taken
on the first post-operative day, blood samples for labora-
tory tests (glycemia, uremia, creatinine, AST, ALT, biliru-
bin, Hb, WBC count, platelet count, PT, PTT) will be
taken on day 1, 3 and 5 and blood samples for biomar-
kers are collected directly after surgery and on day 5. As
mentioned above, one local investigator, blinded for ran-
domization group will score the primary and secondary
post-operative endpoints.
Study endpoints
Primary endpoint - is a composed endpoint of all post-
operative pulmonary complications with each complication
weighing equally; it is presented as a total percentage
of post-operative pulmonary complications. The post-
operative complications are defined as: (a) mild respiratory
failure (PaO2 <60 mmHg or SpO2 <90% in room air but
responding to supplemental oxygen, (b) severe respiratory
failure (need for non-invasive or invasive mechanical venti-
lation or aP a O 2 <60 mmHg or SpO2 <90% despite supple-
mental oxygen), (c) development of ALI/ARDS (according
to consensus guidelines [19]), (d) suspected pulmonary
infection (patient receives antibiotics and meets at least
one of the following criteria: new or changed sputum, new
or changed lung opacities on chest X-ray when clinically
indicated, tympanic temperature >38.3°C, WBC count
>12,000/μl in the absence of other infectious focus), (e)
pulmonary infiltrate (chest X-ray demonstrating unilateral
or bilateral infiltrates), (f) pleural effusion (chest X-ray
demonstrating blunting of the costophrenic angle, loss of
the sharp silhouette of the ipsilateral hemidiaphragm in
upright position, evidence of displacement of adjacent ana-
tomical structures or (in supine position) a hazy opacity in
one hemi-thorax with preserved vascular shadows), (g)
atelectasis (suggested by lung opacification with shift of the
mediastinum, hilum, or hemidiaphragm towards the
affected area, and compensatory overinflation in the adja-
cent non-atelectatic lung), (h) pneumothorax (air in the
pleural space with no vascular bed surrounding the visceral
pleura), (i) bronchospasm (newly detected expiratory
wheezing treated with bronchodilators), (j) aspiration
pneumonitis (respiratory failure after the inhalation of
regurgitated gastric contents), (k) cardiopulmonary edema
(clinical signs of congestion, including dyspnea, edema,
rales and jugular venous distention, with the chest X-ray
demonstrating increase in vascular markings and diffuse
alveolar interstitial infiltrates).
Secondary clinical endpoints - include (a) intra-
operative ventilation strategy related complications
(e.g. de-saturation, hypotension during recruitment
maneuver, need for vasoactive medication), (b) unex-
pected need for ICU admission or ICU readmission,
(c) hospital-free days at follow-up day 90, (d) post-
operative wound healing and (e) post-operative extra-
pulmonary complications. Extra-pulmonary complica-
tions include SIRS, sepsis, severe sepsis, septic shock
(all according to consensus criteria [20]), extra-
pulmonary infection (wound infection or any other
infection), coma (Glasgow Coma Score <8 in the
absence of therapeutic coma or sedation), acute myo-
cardial infarction (according to universal definition of
myocardial infarction [21]), acute renal failure (accord-
ing to the RIFLE classification system [22]), dissemi-
nated intravascular coagulation (according to ISTH
diagnostic scoring system for DIC [23]), gastro-intest-
inal failure (defined as; gastro-intestinal bleeding or
gastro-intestinal failure according to GIF-score [24])
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mg/dL with elevation of the transaminase and lactic
dehydrogenase levels above twice normal values).
Other study parameters - Blood samples will be col-
lected and analyzed for systemic markers of lung injury
(including but not limited to soluble Receptor for
Advanced Glycation Endproducts (sRAGE), Clara Cell
protein-16 (CC-16), surfactant proteins A and D and
levels of proinflammatory and procoagulant/antifibrino-
lytic mediators (including but not limited to interleukin
(IL)-6, IL-8, tumor necrosis factor (TNF)-a, and throm-
bin-antithrombin (TAT), protein C, and plasminogen
activator inhibitor (PAI)-1). The abovementioned bio-
markers of lung injury, acute inflammation and coagulo-
pathy have been shown to correlate with poor clinical
outcome in patients with ALI/ARDS [25]. Notably, with
short-term mechanical ventilation rises in systemic
levels of lung injury biomarkers [26], acute inflammation
[9] and procoagulant/antifibrinolytic mediators [8] have
been described. Lung-protective mechanical ventilation
strategies attenuated the rise in levels of some of the
abovementioned mediators in patients with ALI/ARDS
[27], as well as patients who underwent short-term
mechanical ventilation because of surgery [8,9]. Most of
these trials compared the effect of different tidal
volumes.
The injury induced by mechanical ventilation originates
in the lung, but may also affect distal organs by release of
mediators from the lung into the systemic circulation
[28,29]. Therefore systemic biomarkers of distant organ
injury, in particular the kidney, are determined (includ-
ing, but not limited to neutrophil gelatinase-associated
lipocalin (NGAL) and cystatin C).
Statistical considerations
Sample size calculation - the required sample size is calcu-
lated from an estimated effect size derived from data col-
lected in the ARISCAT study [14] and previous studies on
the incidence of postoperative pulmonary complications
[12,13,30]. A two group c
2 test with a 0.05 two-sided sig-
nificance level will have 80% power to detect the difference
(in post-operative pulmonary complications) between con-
ventional mechanical ventilation (24%) and open lung
mechanical ventilation (16.5%) (Odds ratio of 0.626) when
the sample size in each group is 450.
Interim analysis - one main concern is not to withhold
positive effects of the open lung mechanical ventilation
strategy to the control group. Therefore, interim analyses
are performed after 300 and 600 patients. The first interim
analysis is performed when 300 patients have successfully
been included and followed-up. If the intervention has a
strong trend for improving post-operative pulmonary
complications (as defined above) with a p-value < 0.0005
is found at 300 patients or <0.014 at 600 patients,
termination of the study is considered. The third and final
analysis is performed at 900 patients with a p-value of
0.045 for significance. When post-operative pulmonary
complications occur significantly more frequent in the
intervention group, terminating the study due to harm will
be considered when p ≤ 0.022 for each interim analysis.
Statistical analysis
Normally distributed variables will be expressed by their
mean and standard deviation; not normally distributed
variables will be expressed by their medians and interquar-
tile ranges; categorical variables will be expressed as n (%).
In test groups of continuous normally distributed vari-
ables, Student’s t-test will be used. Likewise if continuous
data are not normally distributed the Mann-Whitney U
test will be used. Categorical variables will be compared
with the Chi-square test or Fisher’se x a c tt e s t so rw h e n
appropriate as relative risks. Where appropriate statistical
uncertainty will be expressed by 95% confidence levels.
Primary outcome is the total occurrence of pulmonary
complications within the first 5 post-operative days, pre-
sented as a percentage. The percentage will be analyzed
as continuous data. If the data is normally distributed,
Student’s t-test will be used or when not normally dis-
tributed the Mann-Whitney U test will be used.
As this is a randomized controlled trial, we expect that
randomization in this large study population will suffi-
ciently balance the baseline characteristics. Baseline bal-
ance is tested and imbalance compensated in all pre-
operative variables and on ARISCAT scores [14] (as
mentioned above). However if imbalance occurs, the
confounding factor will be corrected using a multiple
logistic regression model. For this we will treat the pro-
portion as a binary response (complications occur dur-
ing day one to day five post-operative).
Time to event variables (primary and secondary out-
comes) are analyzed using a proportional hazard model
adjusted for possible imbalances of patients’ baseline char-
acteristics. Time course variables (e.g. repeated measures
of vital parameters, blood values, VAS-scores, actual mobi-
lity) are analyzed by a linear mixed model. The linear
mixed models procedure expands the GLM so that the
data are permitted to exhibit correlated and non-constant
variability. The model includes two factors: 1) study group
(fixed factor, intervention or control group), each level of
the study group factor can have a different linear effect on
the value of the dependent variable; 2) time as a covariate,
time is considered to be a random sample from a larger
population of values, the effect is not limited to the chosen
times.
Study Organization
The Executive Committee is constituted of the study
principal investigator and the principal investigators of
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design and protocol issued to the clinical sites and to
the Data and Safety Monitoring Board (DSMB).
The independent DSMB watches over the ethics of con-
ducting the study in accordance with the Declaration of
Helsinki, monitors patient safety and reviews safety issues
as the study progresses. All serious adverse events, and all
unexpected and related or possibly-related adverse events
will be reported blinded to the appointed international
SAE-manager, who assesses the events and reports this
information to the DSMB within 24 hours of that event in
the case of a serious adverse event or within one week in
the case of an adverse event.
The Steering Committee is composed of the principal
investigators of the principle participating centers who
contribute to the design and revisions of the study
protocol.
The National Coordinators are responsible for admin-
istrative management and communication with the local
principle investigator and provide assistance to the par-
ticipating clinical sites in trial management, record keep-
ing and data management.
Discussion
It has become clear that mechanical ventilation can
attenuate lung damage and may even be the primary fac-
tor in lung injury [2,3]. ALI/ARDS is characterized by het-
erogeneous distribution of pulmonary aeration. During
ventilation the aerated part of the lung receives the largest
part of the tidal volume, potentially causing overdistention
with excessive alveolar wall tension and stress. The non-
aerated atelectatic lung regions are prone to repeated col-
lapse and re-expansion of alveoli, causing shear stress and
diffuse mechanical damage of the alveoli [2,28]. This could
trigger local and systemic inflammation, which has been
suggested to cause ventilator-associated lung injury [1,8,9].
Protective mechanical ventilation using lower tidal
volumes could reduce ventilator-associated lung injury.
Indeed, the use of lower tidal volumes has been found
beneficial in patients who needed long-term mechanical
ventilation for ALI/ARDS [1,15]. Two retrospective stu-
dies [31,32] and one randomized controlled trial [33]
suggest lower tidal volumes to be beneficial in patients
without acute lung injury in long-term ventilation as
well. Other trials suggest that ventilation with lower
tidal volumes is also beneficial in short-term ventilation
for patients without preexisting lung injury [8,9,34]. In
these trials different levels of PEEP were used, making
comparison and interpretation of the additional effect of
PEEP difficult.
During general anesthesia reductions in end-expiratory
lung volume and increases in airway closure is commonly
seen [35]. Both contribute to atelectasis formation. The
most important morbid post-operative pulmonary
complication is atelectasis formation, which increases the
risk for pneumonia and hypoxic acute respiratory failure
[36]. Post-operative pulmonary complications, in particu-
lar post-operative respiratory failure, add to the morbidity
and mortality of surgical patients [12,13]. PEEP prevents
alveolar collapse and atelectasis formation. Recruitment
maneuvers can be used to achieve initial alveolar recruit-
ment [3,37]. Data suggests that recruitment maneuvers
adequately support the beneficial effects of PEEP in short-
term ventilation [38,39]. However, PEEP levels should not
be too high, to avoid overdistention of the lung [1,40].
Various studies showed mechanical ventilation
according to an open lung concept to improve ventila-
tory efficacy of the lungs in patients with healthy lungs
undergoing general anesthesia [3,37]. Studies have
shown the open lung concept to attenuate inflammatory
responses and to prevent loss of functional residual
capacity in cardiac surgery patients [34,41]. Of note,
there is some controversy about the clinical importance
of the cyclic collapse of alveoli. Indeed, the potential of
ventilation strategies with lower tidal volumes and PEEP
for protecting the lungs during the intra-operative per-
iod in patients without previous lung injury has been
questioned [6,7].
T h eP R O V H I L Ot r i a li st h ef i r s tr a n d o m i z e dc o n -
trolled study powered to investigate whether protective
mechanical ventilation using higher levels of PEEP com-
plemented by recruitment maneuvers attenuates post-
operative pulmonary complications. The two ventilation
strategies used in the PROVHILO trial are composed to
match as many clinically applied anesthesia ventilators
as possible. With these standardized ventilation strate-
gies, we aim to minimize variation between ventilation
strategies used in the participating centers.
The primary endpoint of this trial is a composed
endpoint (post-operative pulmonary complications).
This could be seen as a shortcoming, since the effect
of the intervention on one post-operative pulmonary
complication could be diluted if other post-operative
pulmonary complications are not affected, or affected
to a lesser content. However, since we collect and
report on all post-operative pulmonary complications,
it may still be possible to determine the effects on
separate complications.
The main concern in the statistical interim analysis is
not to withhold positive effects of the treatment to the
control group. However, to achieve maximal protection
for patients and to have a lower chance of achieving
positive effects of the intervention on post-operative
pulmonary complications if they were not really present,
different stopping rules are defined for a strong benefi-
cial effect on post-operative pulmonary complications of
the intervention versus a worse effect on post-operative
pulmonary complications.
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Page 7 of 10The spectrum of ventilator-associated lung injury does
not only include pulmonary inflammation, but also an
increase in systemic inflammatory mediators [2,42-44].
The lung has been suggested as an important causative
part of the inflammation-induced systemic disease state
that can evolve to multi-organ failure, rather than
merely a pulmonary disease process. Alveolar collapse
during mechanical ventilation can lead to activation of
inflammatory response both locally and systemically,
which can play a role in modulating the individual
patient’s outcome [3,28,45]. To determine this possible
effect on patients in this trial, secondary endpoints on
extra-pulmonary complications are collected and
reported, as well as blood samples for the determination
of specific markers of distal organ injury.
Several confounding factors can be suggested. Post-
operative pain is a commonly acknowledged contributor
to post-operative atelectasis [46,47]. Respiratory chest phy-
siotherapy has been shown to decrease postoperative
respiratory complications in cardiac surgery, when per-
formed before surgery [48]. It is still uncertain if post-
operative physiotherapeutic procedures are beneficial,
although there is some evidence in favor of physiotherapy
[47]. Excessive intra-operative fluid administration is
another possible contributing factor to the development of
respiratory failure [49]. These factors are not protocolized
by the PROVHILO trial. The protocol stresses that general
anesthesia, post-operative pain management, physiothera-
peutic procedures, fluid management and all other peri-
operative procedures are to be performed according to the
centers’ specific expertise and routine clinical use. We aim
to minimize interference with the effect of PEEP and
recruitment maneuvers on post-operative pulmonary
complications. Suggestions on the abovementioned peri-
operative procedures are made in the protocol, to keep the
variability as small as possibl e .N os u g g e s t i o n sa r em a d e
on type of anesthesia to use, to make the trial as accessible
as possible for anesthesiologists. It is known, however, that
several anesthetic drugs affect lung capacity during surgery
[50,51]. Since we collect a n dr e p o r to na l lc o m m o n l y
known risk factors for post-operative pulmonary compli-
cations and intra-operative administered drugs, it may still
be possible to determine the effect on the primary and sec-
ondary outcomes.
In conclusion, the PROVHILO trial is a worldwide
investigator-initiated randomized controlled trial pow-
ered to test the hypothesis that an open lung mechanical
ventilation strategy using higher levels of PEEP and
recruitment maneuvers during short-term intra-operative
mechanical ventilation prevents against post-operative
pulmonary complications. The PROVHILO trial also
determines the effect of an open lung approach on post-
operative extra-pulmonary complications. Finally, in the
PROVHILO trial the effect of lung-protective mechanical
ventilation is monitored by highly specific biomarkers of
lung injury.
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